Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.
This report aims to provide a comprehensive presentation of the global market for Over the Counter (OTC) Drugs & Dietary Supplements, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over the Counter (OTC) Drugs & Dietary Supplements. This report contains market size and forecasts of Over the Counter (OTC) Drugs & Dietary Supplements in global, including the following market information:
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Over the Counter (OTC) Drugs & Dietary Supplements market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Analgesic & Pain Relievers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Over the Counter (OTC) Drugs & Dietary Supplements include Pfizer Inc., Novartis International AG, Roche Holding AG, Merck & Co., Inc., Sanofi S.A, Johnson & Johnson, Gilead Sciences, GlaxoSmithKline plc. and Bayer Healthcare AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Over the Counter (OTC) Drugs & Dietary Supplements companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Over the Counter (OTC) Drugs & Dietary Supplements Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Segment Percentages, by Type, 2022 (%)
Analgesic & Pain Relievers
Dermatological Products
Cough, Cold, and Flu Products
Vitamin Supplements
Mineral Supplements
Ophthalmic Products
Global Over the Counter (OTC) Drugs & Dietary Supplements Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacy
Others
Global Over the Counter (OTC) Drugs & Dietary Supplements Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Over the Counter (OTC) Drugs & Dietary Supplements Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Over the Counter (OTC) Drugs & Dietary Supplements revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Over the Counter (OTC) Drugs & Dietary Supplements revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
Outline of Major Chapters:
Chapter 1: Introduces the definition of Over the Counter (OTC) Drugs & Dietary Supplements, market overview.
Chapter 2: Global Over the Counter (OTC) Drugs & Dietary Supplements market size in revenue.
Chapter 3: Detailed analysis of Over the Counter (OTC) Drugs & Dietary Supplements company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Over the Counter (OTC) Drugs & Dietary Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Over the Counter (OTC) Drugs & Dietary Supplements Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Over the Counter (OTC) Drugs & Dietary Supplements Overall Market Size
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size: 2022 VS 2029
2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Over the Counter (OTC) Drugs & Dietary Supplements Players in Global Market
3.2 Top Global Over the Counter (OTC) Drugs & Dietary Supplements Companies Ranked by Revenue
3.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Companies
3.4 Top 3 and Top 5 Over the Counter (OTC) Drugs & Dietary Supplements Companies in Global Market, by Revenue in 2022
3.5 Global Companies Over the Counter (OTC) Drugs & Dietary Supplements Product Type
3.6 Tier 1, Tier 2 and Tier 3 Over the Counter (OTC) Drugs & Dietary Supplements Players in Global Market
3.6.1 List of Global Tier 1 Over the Counter (OTC) Drugs & Dietary Supplements Companies
3.6.2 List of Global Tier 2 and Tier 3 Over the Counter (OTC) Drugs & Dietary Supplements Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Markets, 2022 & 2029
4.1.2 Analgesic & Pain Relievers
4.1.3 Dermatological Products
4.1.4 Cough, Cold, and Flu Products
4.1.5 Vitamin Supplements
4.1.6 Mineral Supplements
4.1.7 Ophthalmic Products
4.2 By Type - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue & Forecasts
4.2.1 By Type - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2018-2023
4.2.2 By Type - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2024-2029
4.2.3 By Type - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacy
5.1.5 Others
5.2 By Application - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue & Forecasts
5.2.1 By Application - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2018-2023
5.2.2 By Application - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2024-2029
5.2.3 By Application - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2022 & 2029
6.2 By Region - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue & Forecasts
6.2.1 By Region - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2018-2023
6.2.2 By Region - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2024-2029
6.2.3 By Region - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2018-2029
6.3.2 US Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.3.3 Canada Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.3.4 Mexico Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2018-2029
6.4.2 Germany Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.4.3 France Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.4.4 U.K. Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.4.5 Italy Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.4.6 Russia Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.4.7 Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.4.8 Benelux Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2018-2029
6.5.2 China Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.5.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.5.4 South Korea Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.5.5 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.5.6 India Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2018-2029
6.6.2 Brazil Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.6.3 Argentina Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2018-2029
6.7.2 Turkey Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.7.3 Israel Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.7.4 Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
6.7.5 UAE Over the Counter (OTC) Drugs & Dietary Supplements Market Size, 2018-2029
7 Over the Counter (OTC) Drugs & Dietary Supplements Companies Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Novartis International AG
7.2.1 Novartis International AG Company Summary
7.2.2 Novartis International AG Business Overview
7.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.2.5 Novartis International AG Key News & Latest Developments
7.3 Roche Holding AG
7.3.1 Roche Holding AG Company Summary
7.3.2 Roche Holding AG Business Overview
7.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.3.5 Roche Holding AG Key News & Latest Developments
7.4 Merck & Co., Inc.
7.4.1 Merck & Co., Inc. Company Summary
7.4.2 Merck & Co., Inc. Business Overview
7.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.4.5 Merck & Co., Inc. Key News & Latest Developments
7.5 Sanofi S.A
7.5.1 Sanofi S.A Company Summary
7.5.2 Sanofi S.A Business Overview
7.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.5.5 Sanofi S.A Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Gilead Sciences
7.7.1 Gilead Sciences Company Summary
7.7.2 Gilead Sciences Business Overview
7.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.7.5 Gilead Sciences Key News & Latest Developments
7.8 GlaxoSmithKline plc.
7.8.1 GlaxoSmithKline plc. Company Summary
7.8.2 GlaxoSmithKline plc. Business Overview
7.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.8.5 GlaxoSmithKline plc. Key News & Latest Developments
7.9 Bayer Healthcare AG
7.9.1 Bayer Healthcare AG Company Summary
7.9.2 Bayer Healthcare AG Business Overview
7.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.9.5 Bayer Healthcare AG Key News & Latest Developments
7.10 AstraZeneca plc.
7.10.1 AstraZeneca plc. Company Summary
7.10.2 AstraZeneca plc. Business Overview
7.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.10.5 AstraZeneca plc. Key News & Latest Developments
7.11 Alacer Corp.
7.11.1 Alacer Corp. Company Summary
7.11.2 Alacer Corp. Business Overview
7.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.11.4 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.11.5 Alacer Corp. Key News & Latest Developments
7.12 Alcon Inc.
7.12.1 Alcon Inc. Company Summary
7.12.2 Alcon Inc. Business Overview
7.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.12.4 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.12.5 Alcon Inc. Key News & Latest Developments
7.13 Alfresa Pharma Corporation
7.13.1 Alfresa Pharma Corporation Company Summary
7.13.2 Alfresa Pharma Corporation Business Overview
7.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.13.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.13.5 Alfresa Pharma Corporation Key News & Latest Developments
7.14 Alkalon A/S
7.14.1 Alkalon A/S Company Summary
7.14.2 Alkalon A/S Business Overview
7.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.14.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.14.5 Alkalon A/S Key News & Latest Developments
7.15 Alliance Healthcare
7.15.1 Alliance Healthcare Company Summary
7.15.2 Alliance Healthcare Business Overview
7.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.15.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.15.5 Alliance Healthcare Key News & Latest Developments
7.16 Allergan, Plc.
7.16.1 Allergan, Plc. Company Summary
7.16.2 Allergan, Plc. Business Overview
7.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.16.4 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.16.5 Allergan, Plc. Key News & Latest Developments
7.17 Reckitt Benckiser Plc.
7.17.1 Reckitt Benckiser Plc. Company Summary
7.17.2 Reckitt Benckiser Plc. Business Overview
7.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.17.4 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.17.5 Reckitt Benckiser Plc. Key News & Latest Developments
7.18 Bausch & Lomb
7.18.1 Bausch & Lomb Company Summary
7.18.2 Bausch & Lomb Business Overview
7.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.18.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.18.5 Bausch & Lomb Key News & Latest Developments
7.19 AbbVie Inc.
7.19.1 AbbVie Inc. Company Summary
7.19.2 AbbVie Inc. Business Overview
7.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.19.4 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.19.5 AbbVie Inc. Key News & Latest Developments
7.20 The Colgate-Palmolive Company
7.20.1 The Colgate-Palmolive Company Company Summary
7.20.2 The Colgate-Palmolive Company Business Overview
7.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Major Product Offerings
7.20.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global Market (2018-2023)
7.20.5 The Colgate-Palmolive Company Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Over the Counter (OTC) Drugs & Dietary Supplements Market Opportunities & Trends in Global Market
Table 2. Over the Counter (OTC) Drugs & Dietary Supplements Market Drivers in Global Market
Table 3. Over the Counter (OTC) Drugs & Dietary Supplements Market Restraints in Global Market
Table 4. Key Players of Over the Counter (OTC) Drugs & Dietary Supplements in Global Market
Table 5. Top Over the Counter (OTC) Drugs & Dietary Supplements Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Companies, 2018-2023
Table 8. Global Companies Over the Counter (OTC) Drugs & Dietary Supplements Product Type
Table 9. List of Global Tier 1 Over the Counter (OTC) Drugs & Dietary Supplements Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Over the Counter (OTC) Drugs & Dietary Supplements Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Over the Counter (OTC) Drugs & Dietary Supplements Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Inc. Company Summary
Table 31. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 32. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Inc. Key News & Latest Developments
Table 34. Novartis International AG Company Summary
Table 35. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 36. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis International AG Key News & Latest Developments
Table 38. Roche Holding AG Company Summary
Table 39. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 40. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Holding AG Key News & Latest Developments
Table 42. Merck & Co., Inc. Company Summary
Table 43. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 44. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 45. Merck & Co., Inc. Key News & Latest Developments
Table 46. Sanofi S.A Company Summary
Table 47. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 48. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 49. Sanofi S.A Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 52. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Gilead Sciences Company Summary
Table 55. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 56. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 57. Gilead Sciences Key News & Latest Developments
Table 58. GlaxoSmithKline plc. Company Summary
Table 59. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 60. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 61. GlaxoSmithKline plc. Key News & Latest Developments
Table 62. Bayer Healthcare AG Company Summary
Table 63. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 64. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 65. Bayer Healthcare AG Key News & Latest Developments
Table 66. AstraZeneca plc. Company Summary
Table 67. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 68. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 69. AstraZeneca plc. Key News & Latest Developments
Table 70. Alacer Corp. Company Summary
Table 71. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 72. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 73. Alacer Corp. Key News & Latest Developments
Table 74. Alcon Inc. Company Summary
Table 75. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 76. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 77. Alcon Inc. Key News & Latest Developments
Table 78. Alfresa Pharma Corporation Company Summary
Table 79. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 80. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 81. Alfresa Pharma Corporation Key News & Latest Developments
Table 82. Alkalon A/S Company Summary
Table 83. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 84. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 85. Alkalon A/S Key News & Latest Developments
Table 86. Alliance Healthcare Company Summary
Table 87. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 88. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 89. Alliance Healthcare Key News & Latest Developments
Table 90. Allergan, Plc. Company Summary
Table 91. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 92. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 93. Allergan, Plc. Key News & Latest Developments
Table 94. Reckitt Benckiser Plc. Company Summary
Table 95. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 96. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 97. Reckitt Benckiser Plc. Key News & Latest Developments
Table 98. Bausch & Lomb Company Summary
Table 99. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 100. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 101. Bausch & Lomb Key News & Latest Developments
Table 102. AbbVie Inc. Company Summary
Table 103. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 104. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 105. AbbVie Inc. Key News & Latest Developments
Table 106. The Colgate-Palmolive Company Company Summary
Table 107. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Offerings
Table 108. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$, Mn) & (2018-2023)
Table 109. The Colgate-Palmolive Company Key News & Latest Developments
List of Figures
Figure 1. Over the Counter (OTC) Drugs & Dietary Supplements Segment by Type in 2022
Figure 2. Over the Counter (OTC) Drugs & Dietary Supplements Segment by Application in 2022
Figure 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2022
Figure 8. By Type - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
Figure 9. By Application - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
Figure 10. By Type - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
Figure 12. By Application - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
Figure 14. By Region - Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
Figure 15. By Country - North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
Figure 16. US Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
Figure 20. Germany Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 21. France Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
Figure 28. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 32. India Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
Figure 34. Brazil Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share, 2018-2029
Figure 37. Turkey Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Over the Counter (OTC) Drugs & Dietary Supplements Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
